Skip to Content
MilliporeSigma
  • Method development for impurity profiling in SFC: The selection of a dissimilar set of stationary phases.

Method development for impurity profiling in SFC: The selection of a dissimilar set of stationary phases.

Journal of pharmaceutical and biomedical analysis (2015-01-30)
Charlene Galea, Debby Mangelings, Yvan Vander Heyden
ABSTRACT

Supercritical fluid chromatography (SFC) is drawing considerable interest as separation technique in the pharmaceutical industry. The technique is already well established in chiral separations both analytically and on a preparative scale. The use of SFC as a technique for drug impurity profiling is examined here. To define starting conditions in method development for drug impurity profiling, a set of dissimilar stationary phases is screened in parallel. The possibility to select a set of dissimilar columns using the retention factors (k-values) for a set of 64 drugs measured on 27 columns in SFC was examined. Experiments were carried out at a back-pressure of 150 bar and 25 °C with a mobile phase consisting of CO2 and methanol with 0.1% isopropylamine (5-40% over 10 min) at a flow rate of 3 mL/min. These k-values were then used to calculate correlation coefficients on the one hand and to perform a principal component analysis on the other. The Kennard and Stone algorithm, besides dendrograms and correlation-coefficient colour maps were used to select a set of 6 dissimilar stationary phases. The stationary phase characterization results from this study were compared to those from previous studies found in the literature. Retention mechanisms for compounds possessing different properties were also evaluated. The dissimilarity of the selected subset of 6 stationary phases was validated using mixtures of compounds with similar properties and structures, as one can expect in a drug impurity profile.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Salicylic acid, ReagentPlus®, ≥99%
Sigma-Aldrich
Salicylic acid, meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (calc. to the dried substance)
Sigma-Aldrich
Isopropylamine, ≥99.5%
Sigma-Aldrich
4-Benzylphenol, 99%
Sigma-Aldrich
Methanol, anhydrous, 99.8%
Sigma-Aldrich
Benzylamine, purified by redistillation, ≥99.5%
Sigma-Aldrich
Salicylic acid, ACS reagent, ≥99.0%
Sigma-Aldrich
o-Terphenyl, 99%
Sigma-Aldrich
Benzylamine, ReagentPlus®, 99%
Sigma-Aldrich
Methanol, suitable for HPLC, gradient grade, 99.93%
Sigma-Aldrich
Dopamine hydrochloride
Sigma-Aldrich
Salicylic acid, suitable for plant cell culture
Sigma-Aldrich
Salicylic acid, BioXtra, ≥99.0%
Sigma-Aldrich
Hydrochloric acid solution, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Pindolol, ≥98% (TLC), powder
Sigma-Aldrich
Terazosin hydrochloride, ≥98% (TLC), powder
Sigma-Aldrich
Carbamazepine, meets USP testing specifications
Sigma-Aldrich
Procaine hydrochloride, ≥97%
Sigma-Aldrich
Diclofenac sodium salt
Sigma-Aldrich
Hydrochloric acid, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
Acetylsalicylic acid, analytical standard
Sigma-Aldrich
Nicardipine hydrochloride, powder, ≥98%
Sigma-Aldrich
Pizotifen, ≥98% (HPLC)
Supelco
Salicylic acid, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Salsalate, ≥98% (HPLC)
Sigma-Aldrich
Methanol, HPLC Plus, ≥99.9%, poly-coated bottles
Sigma-Aldrich
1,1-Dimethylbiguanide hydrochloride, 97%
Sigma-Aldrich
Salicylic acid, puriss. p.a., ≥99.0% (T)
Sigma-Aldrich
Hydrochloric acid solution, 0.02 M
Sigma-Aldrich
Methanol, JIS 300, ≥99.8%, for residue analysis